Nicholas J. Douville

Dr. Nicholas J. Douville


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
RBRachel J. Berkowitz
Rachel J. Berkowitz
MEMilo C. Engoren
Milo C. Engoren
GMGraciela Mentz
Graciela Mentz
PSPratima Sharma
Pratima Sharma
SKSathish S. Kumar
Sathish S. Kumar
NDNicholas J. Douville
Nicholas J. Douville
Acute kidney injury (AKI) is one of the most common complications of liver transplantation (LT). We examined the impact of intraoperative management on risk for AKI following LT. In this retrospective observational study, we linked data from the electronic health record with standardized transplant outcomes. Our primary outcome was stage 2 or 3 AKI as defined by Kidney Disease Improving Global Outcomes guidelines within the first 7 days of LT. We used logistic regression models to test the hypothesis that the addition of intraoperative variables, including inotropic/vasopressor administration, transfusion requirements, and hemodynamic markers improves our ability to predict AKI following LT. We also examined the impact of postoperative AKI on mortality. Of the 598 adult primary LT recipients included in our study, 43% (n = 255) were diagnosed with AKI within the first 7 postoperative days. Several preoperative and intraoperative variables including (1) electrolyte/acid‐base balance disorder (International Classification of Diseases, Ninth Revision codes 253.6 or 276.x and International Classification of Diseases, Tenth Revision codes E22.2 or E87.x, where x is any digit; adjusted odds ratio [aOR], 1.917, 95% confidence interval [CI], 1.280–2.869; p = 0.002); (2) preoperative anemia (aOR, 2.612; 95% CI, 1.405–4.854; p = 0.002); (3) low serum albumin (aOR, 0.576; 95% CI, 0.410–0.808; p = 0.001), increased potassium value during reperfusion (aOR, 1.513; 95% CI, 1.103–2.077; p = 0.01), and lactate during reperfusion (aOR, 1.081; 95% CI, 1.003–1.166; p = 0.04) were associated with posttransplant AKI. New dialysis requirement within the first 7 days postoperatively predicted the posttransplant mortality. Our study identified significant association between several potentially modifiable variables with posttransplant AKI. The addition of intraoperative data did not improve overall model discrimination.

1 March 2021 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
NDNicholas J. Douville
Nicholas J. Douville
CDChristopher B. Douville
Christopher B. Douville
GMGraciela Mentz
Graciela Mentz
MMMichael R. Mathis
Michael R. Mathis
CPCarlo Pancaro
Carlo Pancaro
MEMilo Engoren
Milo Engoren

1 January 2020 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
NDNicholas J. Douville
Nicholas J. Douville
EJElizabeth S. Jewell
Elizabeth S. Jewell
NDNeal Duggal
Neal Duggal
RBRoss Blank
Ross Blank
SKSachin Kheterpal
Sachin Kheterpal
MMMichael R. Mathis
Michael R. Mathis
BACKGROUND: “Lung-protective ventilation” describes a ventilation strategy involving low tidal volumes (VTs) and/or low driving pressure/plateau pressure and has been associated with improved outcomes after mechanical ventilation. We evaluated the association between intraoperative ventilation parameters (including positive end-expiratory pressure [PEEP], driving pressure, and VT) and 3 postoperative outcomes: (1) Pao2/fractional inspired oxygen tension (Fio2), (2) postoperative pulmonary complications, and (3) 30-day mortality.METHODS: We retrospectively analyzed adult patients who underwent major noncardiac surgery and remained intubated postoperatively from 2006 to 2015 at a single US center. Using multivariable regressions, we studied associations between intraoperative ventilator settings and lowest postoperative Pao2/Fio2while intubated, pulmonary complications identified from discharge diagnoses, and in-hospital 30-day mortality.RESULTS: Among a cohort of 2096 cases, the median PEEP was 5 cm H2O (interquartile range = 4–6), median delivered VTwas 520 mL (interquartile range = 460–580), and median driving pressure was 15 cm H2O (13–19). After multivariable adjustment, intraoperative median PEEP (linear regression estimate [B] = −6.04; 95% CI, −8.22 to −3.87;P< .001), median Fio2(B = −0.30; 95% CI, −0.50 to −0.10;P= .003), and hours with driving pressure >16 cm H2O (B = −5.40; 95% CI, −7.2 to −4.2;P< .001) were associated with decreased postoperative Pao2/Fio2. Higher postoperative Pao2/Fio2ratios were associated with a decreased risk of pulmonary complications (adjusted odds ratio for each 100 mm Hg = 0.495; 95% CI, 0.331–0.740;P= .001, model C-statistic of 0.852) and mortality (adjusted odds ratio = 0.495; 95% CI, 0.366–0.606;P< .001, model C-statistic of 0.820). Intraoperative time with VT>500 mL was also associated with an increased likelihood of developing a postoperative pulmonary complication (adjusted odds ratio = 1.06/hour; 95% CI, 1.00–1.20;P= .042).CONCLUSIONS: In patients requiring postoperative intubation after noncardiac surgery, increased median Fio2, increased median PEEP, and increased time duration with elevated driving pressure predict lower postoperative Pao2/Fio2. Intraoperative duration of VT>500 mL was independently associated with increased postoperative pulmonary complications. Lower postoperative Pao2/Fio2ratios were independently associated with pulmonary complications and mortality. Our findings suggest that postoperative Pao2/Fio2may be a potential target for future prospective trials investigating the impact of specific ventilation strategies for reducing ventilator-induced pulmonary injury.

11 November 2024 in Anesthesiology
Verified
Journal Article
Open access
PDF file
NDNicholas J. Douville
Nicholas J. Douville
MMMichael Maile
Michael Maile
SKSachin Kheterpal
Sachin Kheterpal
MHMichael Heung
Michael Heung
JSJennifer Schaub
Jennifer Schaub
MKMatthias Kretzler
Matthias Kretzler
ANESTHESIOLOGY is the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative,

9 September 2024 in Anesthesiology
Verified
Journal Article
Open access
PDF file
NDNicholas J. Douville
Nicholas J. Douville
LBLisa Bastarache
Lisa Bastarache
JHJing He
Jing He
KWKuan-Han H. Wu
Kuan-Han H. Wu
BVBrett Vanderwerff
Brett Vanderwerff
MKMiklos D Kertai
Miklos D Kertai
Background: Postoperative nausea and vomiting (PONV) is a key driver of unplanned admission and patient satisfaction after surgery. Because traditional risk factors do not completely explain variability in risk, this study hypothesized that genetics may contribute to the overall risk for this complication. The objective of this research is to perform a genome-wide association study of PONV, derive a polygenic risk score for PONV, assess associations between the risk score and PONV in a validation cohort, and compare any genetic contributions to known clinical risks for PONV. Methods: Surgeries with integrated genetic and perioperative data performed under general anesthesia at Michigan Medicine (Ann Arbor, Michigan) and Vanderbilt University Medical Center (Nashville, Tennessee) were studied. PONV was defined as nausea or emesis occurring and documented in the postanesthesia care unit. In the discovery phase, genome-wide association studies were performed on each genetic cohort, and the results were meta-analyzed. Next, the polygenic phase assessed whether a polygenic score, derived from genome-wide association study in a derivation cohort from Vanderbilt University Medical Center, improved prediction within a validation cohort from Michigan Medicine, as quantified by discrimination (c-statistic) and net reclassification index. Results: Of 64,523 total patients, 5,703 developed PONV (8.8%). The study identified 46 genetic variants exceeding the threshold of P < 1 × 10−5, occurring with minor allele frequency greater than 1%, and demonstrating concordant effects in both cohorts. Standardized polygenic score was associated with PONV in a basic model, controlling for age and sex (adjusted odds ratio, 1.027 per SD increase in overall genetic risk; 95% CI, 1.001 to 1.053; P = 0.044), a model based on known clinical risks (adjusted odds ratio, 1.029; 95% CI, 1.003 to 1.055; P = 0.030), and a full clinical regression, controlling for 21 demographic, surgical, and anesthetic factors, (adjusted odds ratio, 1.029; 95% CI, 1.002 to 1.056; P = 0.033). The addition of polygenic score improved overall discrimination in models based on known clinical risk factors (c-statistic, 0.616 compared to 0.613; P = 0.028) and improved net reclassification of 4.6% of cases. Conclusions: Standardized polygenic risk was associated with PONV in all three of the study’s models, but the genetic influence was smaller than exerted by clinical risk factors. Specifically, a patient with a polygenic risk score greater than 1 SD above the mean has 2 to 3% greater odds of developing PONV when compared to the baseline population, which is at least an order of magnitude smaller than the increase associated with having prior PONV or motion sickness (55%), having a history of migraines (17%), or being female (83%) and is not clinically significant. Furthermore, the use of a polygenic risk score does not meaningfully improve discrimination compared to clinical risk factors and is not clinically useful.

11 September 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
NDNicholas J. Douville
Nicholas J. Douville
MSMark E. Smolkin
Mark E. Smolkin
BNBhiken I. Naik
Bhiken I. Naik
MMMichael Maile
Michael Maile
DCDouglas A. Colquhoun
Douglas A. Colquhoun
RSRobert B. Schonberger
Robert B. Schonberger